|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
D
|
|
INDICATIONS:
|
|
Carcinoma, lung |
|
Carcinoma, testicular |
| |
|
|
SIDE EFFECTS:
|
|
Anemia |
|
leukopenia |
|
thrombocytopenia |
|
Stomatitis |
|
Anaphylaxis |
|
chemical phlebitis |
|
neurotoxicity |
|
skin rash or itching |
|
Loss of appetite |
|
nausea and vomiting |
|
Central nervous system (CNS) toxicity |
|
diarrhea |
|
Alopecia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Bone marrow depression |
|
>> Chickenpox, existing |
|
>> Herpes zoster |
|
Hepatic function impairment |
|
>> Infection |
|
Renal function impairment |
|
Sensitivity to etoposide |
|
|
ADULT DOSE:
|
|
Small cell lung carcinoma-Oral, 70 mg (base) per square meter of body surface area (rounded to the nearest 50 mg) per day for four days to 100 mg per square meter of body surface area (rounded to the nearest 50 mg) per day for five days, repeated every three to four weeks. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dosage has not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|